Loading events...
Christina Schwarz will speak on the panel “Exploring New Litigation Concerns from Amneal and The FTC’s Latest Call for Orange Book Delistings” at ACI’s Inaugural Summit on Pharma & Biotech Patent Litigation USA in NYC on October 14 – 15. The panel will examine how the recent Teva v. Amneal ruling will impact Orange Book patents and Hatch-Waxman litigation.
Tuesday, October 14, 2025 - Wednesday, October 15, 2025
New York, USA
Christina Schwarz will speak on the panel “Exploring New Litigation Concerns from Amneal and The FTC’s Latest Call for Orange Book Delistings” at ACI’s Inaugural Summit on Pharma & Biotech Patent Litigation USA in NYC on October 14 – 15. The panel will examine how the recent Teva v. Amneal ruling will impact Orange Book patents and Hatch-Waxman litigation.
Receive curated event recommendations based on your interests.
See how WebMobi helps you manage registration, check-in, and analytics.
Request a DemoOr start free trial →ACI’s Inaugural Summit on Pharma & Biotech Patent Litigation USA 2025 takes place on Tuesday, October 14, 2025 to Wednesday, October 15, 2025.
ACI’s Inaugural Summit on Pharma & Biotech Patent Litigation USA 2025 is held in New York, USA at 3 Times Square.
Pricing information is available on the event website.
ACI’s Inaugural Summit on Pharma & Biotech Patent Litigation USA 2025 is designed for healthcare professionals looking to network, learn, and discover new opportunities.
Get curated B2B events, AI-powered insights, and industry trends delivered to your inbox